Myriad Genetics Inc.

MYGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.01

+$0.12 (+3.08%)

At close: Sep 21, 2026, 4:00 PM ET

$3.87

-$0.14 (-3.49%)

Pre-market: Sep 22, 2026, 8:53 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-365.9M	-127.3M	-263.3M	-112M	-27.2M	-223.7M
Depreciation & Amortization	53.7M	61.2M	61.9M	52.7M	62.8M	71.4M
Stock-Based Compensation	35.2M	49.8M	40.7M	38.1M	36.3M	24.3M
Other Working Capital	-20.9M	-44.2M	28.7M	-84.8M	118.8M	n/a
Other Non-Cash Items	330.5M	62.3M	23.4M	30.3M	-139.4M	125.4M
Deferred Income Tax	-32.4M	-300K	-600K	-31.9M	-34.7M	-54.5M
Change in Working Capital	-19.3M	-54.4M	27M	-83.5M	120.8M	30.2M
Operating Cash Flow	1.8M	-8.7M	-110.9M	-106.3M	18.6M	-26.9M
Capital Expenditures	-27.4M	-29.7M	-73.3M	-45.3M	-18M	-13.2M
Cash Acquisitions	n/a	8.8M	n/a	-57.2M	379.1M	n/a
Purchase of Investments	n/a	n/a	n/a	-103.2M	-147.8M	n/a
Sales Maturities Of Investments	n/a	9M	105.2M	128.2M	61.1M	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	74.8M
Investing Cash Flow	-27.4M	-11.9M	31.9M	-77.5M	274.4M	61.6M
Debt Repayment	84.3M	100K	39.8M	n/a	-226.4M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-3.9M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-23.4M	-7.5M	-4.5M	-8M	-16M	-1M
Financial Cash Flow	64.2M	-7.4M	152.9M	-8M	-150.6M	-1M
Net Cash Flow	39.4M	-29M	74.5M	-192.4M	141.8M	70.5M
Free Cash Flow	-25.6M	-38.4M	-184.2M	-151.6M	600K	-40.1M
Adj. Free Cash Flow	-60.8M	-88.2M	-224.9M	-189.7M	-35.7M	-64.4M
Maintenance CapEx	-27.4M	-14.85M	-61.93M	-45.3M	-4.92M	-13.2M
Growth CapEx	n/a	-14.85M	-11.37M	n/a	-13.08M	n/a
Owner Earnings	-25.6M	-23.55M	-172.83M	-151.6M	13.68M	-40.1M